London · Delayed Price · Currency is GBP · Price in GBX Mereo BioPharma Group Statistics
Total Valuation
AIM:MPH has a market cap or net worth of GBP 28.14 million. The enterprise value is -1.82 million.
| Market Cap | 28.14M |
| Enterprise Value | -1.82M |
Important Dates
The next estimated earnings date is Monday, May 11, 2026.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.77% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 114.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 75.75 |
| PB Ratio | 0.93 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.06 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.08 |
Financial Position
The company has a current ratio of 10.46, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.46 |
| Quick Ratio | 9.99 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -151.20 |
Financial Efficiency
Return on equity (ROE) is -82.21% and return on invested capital (ROIC) is -44.41%.
| Return on Equity (ROE) | -82.21% |
| Return on Assets (ROA) | -39.41% |
| Return on Invested Capital (ROIC) | -44.41% |
| Return on Capital Employed (ROCE) | -92.65% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9,526 |
| Profits Per Employee | -797,830 |
| Employee Count | 39 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -5.36% |
| 50-Day Moving Average | 33.69 |
| 200-Day Moving Average | 34.79 |
| Relative Strength Index (RSI) | 17.95 |
| Average Volume (20 Days) | 133,356 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.48 |
Income Statement
In the last 12 months, AIM:MPH had revenue of GBP 371,500 and -31.12 million in losses. Loss per share was -0.20.
| Revenue | 371,500 |
| Gross Profit | 272,681 |
| Operating Income | -28.65M |
| Pretax Income | -31.12M |
| Net Income | -31.12M |
| EBITDA | -28.19M |
| EBIT | -28.65M |
| Loss Per Share | -0.20 |
Balance Sheet
The company has 30.46 million in cash and 150,086 in debt, with a net cash position of 30.31 million.
| Cash & Cash Equivalents | 30.46M |
| Total Debt | 150,086 |
| Net Cash | 30.31M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 30.40M |
| Book Value Per Share | 0.19 |
| Working Capital | 30.25M |
Cash Flow
In the last 12 months, operating cash flow was -23.01 million and capital expenditures -14,860, giving a free cash flow of -23.03 million.
| Operating Cash Flow | -23.01M |
| Capital Expenditures | -14,860 |
| Depreciation & Amortization | 456,552 |
| Net Borrowing | n/a |
| Free Cash Flow | -23.03M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 73.40% |
| Operating Margin | -7,711.40% |
| Pretax Margin | -8,375.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:MPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.77% |
| Shareholder Yield | -7.77% |
| Earnings Yield | -110.57% |
| FCF Yield | -81.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AIM:MPH has an Altman Z-Score of 25.39 and a Piotroski F-Score of 2.
| Altman Z-Score | 25.39 |
| Piotroski F-Score | 2 |